Trial intelligence / Profile preview

Intra-tumoural Hydrogen Peroxide as Radiation Sensitizer in Breast Cancer

NCT02757651Phase 2Completed

Sponsor
The Institute of Cancer Research
Start
Jan 2017
Primary completion
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of hydrogen peroxide in breast cancer, sponsored by The Institute of Cancer Research. Started Jan 2017; status: completed.

02

Drugs

hydrogen peroxide
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT02757651.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02757651.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call